CRYBA4: A Potential Drug Target and Biomarker for 尾-Crystallin A4 Isomer X1

Target Name: CRYBA4

NCBI ID: G1413

CRYBA4

CRYBA4: A Potential Drug Target and Biomarker for 尾-Crystallin A4 Isomer X1

Abstract:

尾-Crystallin A4 (尾-Cryin) is a protein that plays a crucial role in maintaining the structure and stability of lens cells, which are responsible for vision. 尾-Cryin is a large transmembrane protein that contains multiple distinct isoforms. In this article, we discuss the potential implications of CRYBA4 as a drug target and biomarker for 尾-Cryin A4 isomer X1.

Introduction:

尾-Crystallin A4 (尾-Cryin) is a protein that is expressed in high abundance in the lens cells, which are responsible for maintaining vision. The lens cells are specialized cells that transmit light from the eye to the brain. They are crucial for maintaining visual acuity and the overall quality of vision.

尾-Cryin is a large transmembrane protein that contains multiple distinct isoforms. These isoforms are generated through alternative splicing of the 尾-Cryin gene. The most abundant isoform is 尾-Cryin A4 (尾-Cryin A4 isoform X1), which is primarily expressed in the lens cortex. Other isoforms include 尾-Cryin A3 (尾-Cryin A3 isoform X2), 尾-Cryin A5 (尾-Cryin A5 isoform X3), and 尾-Cryin A6 (尾-Cryin A6 isoform X4).

尾-Cryin A4 is the most abundant isoform of 尾-Cryin in the lens cortex, and it is responsible for maintaining the structure and stability of the lens cells. It plays a crucial role in the regulation of cell survival, as well as the formation of the lens material.

As a drug target, 尾-Cryin A4 may be a promising target for the development of therapies for a variety of eye diseases, including age-related macular degeneration (AMD), diabetic retinopathy, and cataracts.

In addition to its potential as a drug target, 尾-Cryin A4 may also be a useful biomarker for tracking the progression of these diseases. The levels of 尾-Cryin A4 in the lens cortex can be affected by a variety of factors, including aging , diabetes, and other diseases. By monitoring the levels of 尾-Cryin A4 in the lens cortex, researchers may be able to develop more accurate diagnostic tools for these diseases.

尾-Cryin A4 as a drug target:

尾-Cryin A4 is a protein that is involved in the regulation of cell survival and the formation of the lens material. It plays a crucial role in the development and maintenance of the lens cortex, as well as the regulation of cell survival.

尾-Cryin A4 is a large transmembrane protein that contains multiple distinct isoforms. These isoforms are generated through alternative splicing of the 尾-Cryin gene. The most abundant isoform is 尾-Cryin A4 (尾-Cryin A4 isoform X1), which is primarily expressed in the lens cortex.

尾-Cryin A4 is involved in the regulation of cell survival by promoting the survival of retinal epithelial cells and by inhibiting the survival of photoreceptor cells. It does this by interacting with several different signaling pathways, including the TGF-β pathway and the Wnt pathway.

In addition to its role in cell survival, 尾-Cryin A4 is also involved in the formation of the lens material. It plays a crucial

Protein Name: Crystallin Beta A4

Functions: Crystallins are the dominant structural components of the vertebrate eye lens

The "CRYBA4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CRYBA4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets